Changqing Xie

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 31

Top Topics

Liver Metastases

Metastatic Colorectal Cancer

Top Venues

Nature communications

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Hu Liang, Yao-Fei Jiang, Guo-Ying Liu, Lin Wang, Jian-Wei Wang, Nian Lu, Wei-Xiong Xia, Liang-Ru Ke, Yan-Fang Ye, Jin-Lin Duan, Wei-Xin Bei, Shu-Hui Dong, Wang-Zhong Li, Li-Ting Liu, Chong Zhao, Changqing Xie, Yan-Qun Xiang
Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial. Nature communications 15 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Hu Liang, Yao-Fei Jiang, Guo-Ying Liu, Lin Wang, Jian-Wei Wang, Nian Lu, Wei-Xiong Xia, Liang-Ru Ke, Yan-Fang Ye, Jin-Lin Duan, Wei-Xin Bei, Shu-Hui Dong, Wang-Zhong Li, Li-Ting Liu, Chong Zhao, Changqing Xie, Yan-Qun Xiang
Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial. Nature communications 15 (1) (2024)
Hu Liang, Yao-Fei Jiang, Guo-Ying Liu, Lin Wang, Jian-Wei Wang, Nian Lu, Wei-Xiong Xia, Liang-Ru Ke, Yan-Fang Ye, Jin-Lin Duan, Wei-Xin Bei, Shu-Hui Dong, Wang-Zhong Li, Li-Ting Liu, Chong Zhao, Changqing Xie, Yan-Qun Xiang
Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial. Nature communications 15 (1) (2024)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M Hernandez, Bradford J Wood, Elliot B Levy, Israa Juburi, Stephen M Hewitt, David E Kleiner, Seth M Steinberg, William D Figg, Bernadette Redd, Philip Homan, Maggie Cam, Benjamin Ruf, Austin G Duffy, Tim F Greten
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. Journal for immunotherapy of cancer 11 (2) (2023)
Wenquan Ou, Samantha Stewart, Alisa White, Elyahb A Kwizera, Jiangsheng Xu, Yuanzhang Fang, James G Shamul, Changqing Xie, Suliat Nurudeen, Nikki P Tirada, Xiongbin Lu, Katherine H R Tkaczuk, Xiaoming He
In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy. Nature communications 14 (1) (2023)
Wenquan Ou, Samantha Stewart, Alisa White, Elyahb A Kwizera, Jiangsheng Xu, Yuanzhang Fang, James G Shamul, Changqing Xie, Suliat Nurudeen, Nikki P Tirada, Xiongbin Lu, Katherine H R Tkaczuk, Xiaoming He
In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy. Nature communications 14 (1) (2023)
Jyotsna Gummadi, Xin Wang, Changqing Xie
Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver. Journal of hepatocellular carcinoma 10 (2023)
Xin Wang, Jihye L Golino, Nga Voong Hawk, Changqing Xie
Reciprocal Interaction of Cancer Stem Cells of Cholangiocarcinoma with Macrophage. Stem cell reviews and reports (2023)
Wenquan Ou, Samantha Stewart, Alisa White, Elyahb A Kwizera, Jiangsheng Xu, Yuanzhang Fang, James G Shamul, Changqing Xie, Suliat Nurudeen, Nikki P Tirada, Xiongbin Lu, Katherine H R Tkaczuk, Xiaoming He
In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy. Nature communications 14 (1) (2023)
Jihye L Golino, Xin Wang, Jing Bian, Benjamin Ruf, Michael Kelly, Baktiar O Karim, Maggie C Cam, Changqing Xie
Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma. Cancers 15 (9) (2023)
Yilun Sun, Simone A Baechler, Xiaohu Zhang, Suresh Kumar, Valentina M Factor, Yasuhiro Arakawa, Cindy H Chau, Kanako Okamoto, Anup Parikh, Robert L Walker, Yijun P Su, Jiji Chen, Tabitha Ting, Shar-Yin N Huang, Erin Beck, Zina Itkin, Crystal McKnight, Changqing Xie, Nitin Roper, Deepak Nijhawan, William Douglas Figg, Paul S Meltzer, James C Yang, Craig J Thomas, Yves Pommier
Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex. Nature communications 14 (1) (2023)
Jihye L Golino, Xin Wang, Hoyoung M Maeng, Changqing Xie
Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics. Cells 12 (6) (2023)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M Hernandez, Bradford J Wood, Elliot B Levy, Israa Juburi, Stephen M Hewitt, David E Kleiner, Seth M Steinberg, William D Figg, Bernadette Redd, Philip Homan, Maggie Cam, Benjamin Ruf, Austin G Duffy, Tim F Greten
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. Journal for immunotherapy of cancer 11 (2) (2023)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M Hernandez, Bradford J Wood, Elliot B Levy, Israa Juburi, Stephen M Hewitt, David E Kleiner, Seth M Steinberg, William D Figg, Bernadette Redd, Philip Homan, Maggie Cam, Benjamin Ruf, Austin G Duffy, Tim F Greten
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. Journal for immunotherapy of cancer 11 (2) (2023)
Wenquan Ou, Samantha Stewart, Alisa White, Elyahb A Kwizera, Jiangsheng Xu, Yuanzhang Fang, James G Shamul, Changqing Xie, Suliat Nurudeen, Nikki P Tirada, Xiongbin Lu, Katherine H R Tkaczuk, Xiaoming He
In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy. Nature communications 14 (1) (2023)
Wenquan Ou, Samantha Stewart, Alisa White, Elyahb A Kwizera, Jiangsheng Xu, Yuanzhang Fang, James G Shamul, Changqing Xie, Suliat Nurudeen, Nikki P Tirada, Xiongbin Lu, Katherine H R Tkaczuk, Xiaoming He
In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy. Nature communications 14 (1) (2023)
Wenquan Ou, Samantha Stewart, Alisa White, Elyahb A Kwizera, Jiangsheng Xu, Yuanzhang Fang, James G Shamul, Changqing Xie, Suliat Nurudeen, Nikki P Tirada, Xiongbin Lu, Katherine H R Tkaczuk, Xiaoming He
In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy. Nature communications 14 (1) (2023)
Jihye L Golino, Xin Wang, Hoyoung M Maeng, Changqing Xie
Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics. Cells 12 (6) (2023)
Jihye L Golino, Xin Wang, Hoyoung M Maeng, Changqing Xie
Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics. Cells 12 (6) (2023)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M Hernandez, Bradford J Wood, Elliot B Levy, Israa Juburi, Stephen M Hewitt, David E Kleiner, Seth M Steinberg, William D Figg, Bernadette Redd, Philip Homan, Maggie Cam, Benjamin Ruf, Austin G Duffy, Tim F Greten
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. Journal for immunotherapy of cancer 11 (2) (2023)
Jihye L Golino, Xin Wang, Jing Bian, Benjamin Ruf, Michael Kelly, Baktiar O Karim, Maggie C Cam, Changqing Xie
Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma. Cancers 15 (9) (2023)
Cecilia Monge Bonilla, Erica C Pehrsson, Changqing Xie, Austin G Duffy, Donna Mabry, Bradford J Wood, David E Kleiner, Seth M Steinberg, William Douglas Figg, Bernadette Redd, Anuradha Budhu, Sophie Wang, Mayank Tandon, Lichun Ma, Xin Wei Wang, Tim F Greten
A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma. The oncologist 27 (3) (2022)
Xin Wang, Jihye L Golino, Changqing Xie
Autophagy Regulation on Cancer Stem Cell Maintenance, Metastasis, and Therapy Resistance. Cancers 14 (2) (2022)
Jing Bian, Jianyang Fu, Xin Wang, Jihye L Golino, Gagandeep Brar, Freddy E Escorcia, Margaret C Cam, Changqing Xie
Characterization of Immunogenicity of Malignant Cells with Stemness in Intrahepatic Cholangiocarcinoma by Single-Cell RNA Sequencing. Stem cells international 2022 (2022)
Changqing Xie, Nicole A McGrath, Cecilia Monge Bonilla, Jianyang Fu
Systemic treatment options for advanced biliary tract carcinoma. Journal of gastroenterology 55 (10) (2020)